Cardiovascular Drugs And Therapy

Journal Title：Cardiovascular Drugs And Therapy

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

旨在客观地涵盖心血管药物、器械和细胞疗法的从实验室到临床的开发过程，并以及时和有用的形式为您提供您最需要的信息，心血管药物和治疗以新鲜和充满活力的视角在这个动态领域取得进展。

Cardiovascular Drugs and Therapy 专注于新治疗药物方面最激动人心的工作，重点关注动脉粥样硬化、高脂血症、糖尿病、缺血性综合征和心律失常的发展。该杂志是当前和相关信息的权威来源，对于旨在进行新颖、突破性研究的基础和临床研究人员以及寻求为患者提供最佳服务的心脏病专家而言，这些信息必不可少。

为您提供一个公认的世界上最好的单一、简洁的参考工具，心血管药物和治疗被列在 Web of Science 和 PubMed/Medline 以及其他摘要和索引服务中。定期文章和频繁的专题问题为您提供了一个最新的资源，该资源由对不断发展的领域的准确信息的需求定义。 Cardiovascular Drugs and Therapy 是一个仔细而准确的指南，通过迷宫般的新产品和疗法为您提供心血管药理学的详细信息，您将一次又一次地参考。

Cardiovascular Drugs And Therapy创刊于1987年，由SPRINGER出版商出版，收稿方向涵盖医学 - 心血管系统全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度约4.5月，影响因子指数4.069，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。